Maria Smith, Ph.D.

Goodwin

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Coherus Biosciences Announces Approval of a Pegfilgrastim Autoinjector

On March 6, 2023, Coherus Biosciences announced FDA approval of an autoinjectable version of Udenyca, Coherus’ biosimilar to Amgen’s Neulasta (pegfilgrastim). Udenyca (pegfilgrastim-cbqv) was first launched in the US in...more

3/14/2023  /  Biosimilars , Coherus , FDA Approval , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs

Sandoz denosumab BLA accepted by US FDA

​​​​​​​The US FDA has accepted a Biologics License Application (BLA) from Sandoz for a proposed denosumab biosimilar. ...more

2/28/2023  /  Biologics , Food and Drug Administration (FDA) , Pharmaceutical Patents , Sandoz
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide